At the news
? NEUTRALIMPACT 3/10 144 filed Nov 12, 2026 at 07:56 ET
Jack Anders, an officer of Revolution Medicines, filed a Form 144 notice to sell 35,750 shares of common stock with an estimated aggregate market value of approximately $6.9 million. The shares were acquired through the exercise of stock options on November 11, 2026, and the sale was executed on the same day. The filing was delayed by one day due to the Veterans Day federal holiday.
- Reporting person: Jack Anders, an officer of Revolution Medicines, Inc.
- Securities to be sold: 35,750 shares of common stock
- Estimated aggregate market value: approximately $6,901,895
- Shares acquired on November 11, 2026 via exercise of stock options from the issuer
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access